{"schemaVersion":1,"research":true,"symbol":"met","name":"Metlife","topic":"moat","path":"/stock/met/moat","status":"published","version":4,"updatedAt":"2026-10-18T13:26:11.959Z","locked":false,"publicFairValue":false,"fairValue":null,"moat":{"verdict":"uncertain","summary":"MetLife has a substantial operating franchise, ratings-supported funding access and some contractual customer lock-in, but the supplied passages do not establish a durable competitive advantage across the business. Service achievements and reported persistency support customer demand without proving superior retention or pricing power. Renewable group policies permit repricing, while guarantees and regulation constrain other products. Competitive disadvantages are disclosed, but realized franchise deterioration sufficient for a no-moat verdict is not established.","advantages":[{"mechanism":"intangible_assets","claim":"Ratings-supported funding access and reported customer-service achievements are current franchise strengths. A durable brand premium or funding advantage relative to competitors remains unestablished.","durability":"Conditional on financial strength and service execution; the passages do not demonstrate sustained comparative superiority.","risks":"Some competitors have more competitive pricing or higher claims-paying ratings. Technology and distribution changes could weaken differentiation.","invalidation":"The candidate advantage would be undermined by loss of competitively priced funding access, sustained deterioration in service benchmarks, or persistent customer losses attributable to inferior pricing or financial strength.","competitors":["AIG","Manulife","Dai-ichi","Prudential plc","Allstate","Prudential"],"evidenceIds":["e1","e2","e3","e4","e5"],"counterEvidenceIds":["e6","e7"]},{"mechanism":"switching_costs","claim":"Certain guaranteed payout annuities have no loan or cash surrender value, creating contractual persistence for that existing business. This does not establish an advantage in winning new contracts or repricing existing liabilities.","durability":"The contractual restriction lasts with the relevant contracts, but its contribution to company-wide economic returns is not quantified.","risks":"Locked-in liabilities also bind MetLife to benefit commitments. Renewable group products have different economics, and customers can compare providers for new business.","invalidation":"A company-wide switching-cost thesis would fail if the restricted contracts represent an immaterial share of economics, if replacement or termination is practically inexpensive, or if persistent contracts fail to earn adequate risk-adjusted returns.","competitors":[],"evidenceIds":["e8","e9"],"counterEvidenceIds":["e10","e11"]}],"evidence":[{"id":"e1","sourceId":"filing-2","location":"Liquidity and Capital Resources — ratings-supported wholesale funding access","excerpt":"MetLife, Inc.’s ability to maintain regular access to competitively priced wholesale funds is fostered by its current credit ratings from the major credit rating agencies."},{"id":"e2","sourceId":"filing-3","location":"Executive performance — call center customer satisfaction","excerpt":"•Advanced customer loyalty and service excellence, achieving top quartile call center customer satisfaction across the Company's six largest markets."},{"id":"e3","sourceId":"filing-3","location":"Executive performance footnote — customer-service recognition methodology","excerpt":"1J.D. Power 2025 Certified Customer Service ProgramSM recognition is based on successful completion of an evaluation and exceeding a customer satisfaction"},{"id":"e4","sourceId":"filing-3","location":"Compensation — identification of business and/or investor competitors","excerpt":"The Performance Share TSR Peer Group includes MetLife’s key publicly traded insurance company competitors for business and/or investors."},{"id":"e5","sourceId":"filing-3","location":"Compensation — comparator and performance-share peer names","excerpt":"Compensation Comparator Group: Insurance and Financial Services Companies (with ticker symbol) Aflac (AFL) The Hartford (HIG) Allianz (ALV) Principal Financial (PFG) Performance Share TSR Peers: Insurance Companies (with ticker symbol) AIG (AIG) Manulife (MFC) Dai-ichi (8750) Prudential plc (PRU LN) Allstate (ALL) Prudential (PRU) Globe Life Inc."},{"id":"e6","sourceId":"filing-1","location":"Business — Competition — competing products, prices and ratings","excerpt":"Some of our competitors offer a broader array of products, have more competitive pricing or, with respect to other insurance companies, have higher claims paying ability ratings."},{"id":"e7","sourceId":"filing-1","location":"Risk Factors — potential competitive harm from technology adoption","excerpt":"We may fail to adopt new technologies as effectively or efficiently as others, leading to competitive harm, or we may fail to adjust our investments accordingly or suffer stranded assets."},{"id":"e8","sourceId":"filing-1","location":"Business — guaranteed payout annuity product description","excerpt":"General account contracts that are guaranteed payout annuities purchased for employees upon retirement or termination of employment."},{"id":"e9","sourceId":"filing-1","location":"Business — annuity surrender and future-consideration restrictions","excerpt":"Contracts can be life or non-life contingent non-participating contracts which do not provide for any loan or cash surrender value and, with few exceptions, do not permit future considerations."},{"id":"e10","sourceId":"filing-1","location":"Interest-rate scenarios — renewable group life policies","excerpt":"Declining Interest Rate Scenario. Our group life insurance products are primarily renewable term policies."},{"id":"e11","sourceId":"filing-1","location":"Business — guaranteed benefits supported by separate accounts","excerpt":"The assets supporting the guaranteed benefits for each contract are held in a separate account, however, the Company fully guarantees all benefit payments."},{"id":"e12","sourceId":"filing-1","location":"Interest-rate scenarios — group life repricing flexibility","excerpt":"This provides repricing flexibility to mitigate the negative impact of reinvesting in lower yielding assets."},{"id":"e13","sourceId":"filing-1","location":"Interest-rate scenarios — retained asset account guarantees","excerpt":"Our retained asset accounts experience gross margin compression due to minimum crediting rate guarantees."},{"id":"e14","sourceId":"filing-1","location":"Interest-rate scenarios — disability reserve crediting-rate constraints","excerpt":"Additionally, we experience gross margin compression from our disability policy claim reserves for which crediting rates cannot be reduced."},{"id":"e15","sourceId":"filing-1","location":"Interest-rate scenarios — derivative mitigation of margin compression","excerpt":"We use interest rate derivatives to mitigate gross margin compression for both products."},{"id":"e16","sourceId":"filing-1","location":"Interest-rate scenarios — group disability renewal adjustments","excerpt":"Gross margin compression is limited for our group disability products, which are generally renewable term policies allowing for crediting rate adjustments at renewal based on the retrospective experience rating and the prevailing interest rate assumptions."},{"id":"e17","sourceId":"filing-1","location":"Regulatory risks — potential limitations on contemporaneous repricing","excerpt":"Our ability to react to rapidly changing economic conditions and the dynamic, competitive markets may be impaired if our product designs do not allow frequent and contemporaneous revisions of key pricing elements, or if we are unable to work collaboratively with regulators."},{"id":"e18","sourceId":"filing-6","location":"Consolidated results — revenue growth, persistency and acquisition contribution","excerpt":"Adjusted premiums, fees and other revenues, net of foreign currency fluctuations, increased $370 million, or 3%, compared to the prior period, primarily due to strong sales and solid persistency in the Latin America segment, growth in both voluntary and core products in the Group Benefits segment, growth across the region in the EMEA segment, and the PineBridge acquisition that was completed in December 2025 in the MIM segment, partially offset by a decline in Corporate & Other from business run-off."},{"id":"e19","sourceId":"filing-3","location":"Financial measures — GAAP earnings, common equity returns, expenses and parent cash generation","excerpt":"You should not view these Non-GAAP financial measures as substitutes for the most directly comparable financial measures calculated in accordance with GAAP: ($ in millions, except per share data and as otherwise indicated) 2024 2025 Net income (loss) available to MetLife, Inc.’s common shareholders $4,226 $3,173 Net income (loss) available to MetLife, Inc.’s common shareholders per diluted common share $5.94 $4.71 Return on MetLife, Inc.’s common stockholder equity 16.9% 12.9% Expense ratio 19.0% 18.5% Ratio of net cash provided by operating activities (parent company only) to consolidated net income (loss) available to MetLife, Inc.’s common shareholders1 112% 90% 1Ratio of net cash provided by operating activities (parent company only) to consolidated net income (loss) available to MetLife, Inc.’s common shareholders is 303% for the year ended December 31, 2023."},{"id":"e20","sourceId":"filing-2","location":"Consolidated Results — first-half 2026 and 2025 revenues, expenses and earnings","excerpt":"102 Table of Contents Consolidated Results Three Months Ended June 30, Six Months Ended June 30, 2026 2025 2026 2025 (In millions) Revenues Premiums $ 11,435 $ 10,810 $ 23,555 $ 22,533 Universal life and investment-type product policy fees 1,372 1,259 2,715 2,488 Net investment income 6,702 5,661 12,057 10,546 Other revenues 845 679 1,697 1,366 Net investment gains (losses) (428) (273) (1,098) (660) Net derivative gains (losses) (772) (796) (698) (364) Total revenues 19,154 17,340 38,228 35,909 Expenses Policyholder benefits and claims and policyholder dividends 11,460 10,913 23,448 22,863 Policyholder liability remeasurement (gains) losses 18 5 5 (26) Market risk benefit remeasurement (gains) losses (270) (277) (150) 22 Interest credited to policyholder account balances 3,067 2,400 4,741 4,047 Amortization of deferred policy acquisition costs, value of business acquired and negative value of business acquired 588 528 1,156 1,047 Interest expense on debt 292 269 557 527 Other expenses, net of capitalization of deferred policy acquisition costs 2,964 2,522 5,929 5,095 Total expenses 18,119 16,360 35,686 33,575 Income (loss) before provision for income tax 1,035 980 2,542 2,334 Provision for income tax expense (benefit) 256 245 601 649 Net income (loss) 779 735 1,941 1,685 Less: Net income (loss) attributable to noncontrolling interests and redeemable noncontrolling interests 43 6 20 11 Net income (loss) attributable to MetLife, Inc."},{"id":"e21","sourceId":"filing-2","location":"Consolidated Results — income attributable to MetLife and common shareholders","excerpt":"736 729 1,921 1,674 Less: Preferred stock dividends 31 31 76 97 Net income (loss) available to MetLife, Inc.’s common shareholders $ 705 $ 698 $ 1,845 $ 1,577 Three Months Ended June 30, 2026 Compared with the Three Months Ended June 30, 2025 Discussions below are presented in order of magnitude."},{"id":"e22","sourceId":"filing-1","location":"Regulation — numerator and subsidiary scope of internally defined combined RBC ratio","excerpt":"We calculate our internally defined “Statement-Based Combined RBC Ratio” by dividing the sum of total adjusted capital for MetLife, Inc.’s principal U.S."},{"id":"e23","sourceId":"filing-1","location":"Regulation — company action level RBC denominator and exclusions","excerpt":"insurance subsidiaries, excluding American Life Insurance Company (“American Life”), by the sum of company action level RBC for such subsidiaries, including annual Special Considerations Letters (“SCL\"), as discussed below."},{"id":"e24","sourceId":"filing-1","location":"Regulation — year-end 2025 and 2024 combined RBC ratio lower bounds","excerpt":"Our Statement-Based Combined RBC Ratio was in excess of 350% and in excess of 360% at December 31, 2025 and 2024, respectively."},{"id":"e25","sourceId":"filing-2","location":"Liquidity — holding-company liquid assets","excerpt":"Liquid Assets At June 30, 2026 and December 31, 2025, MetLife holding companies had $3.4 billion and $3.6 billion, respectively, in liquid assets."},{"id":"e26","sourceId":"filing-2","location":"Liquidity — regulatory restrictions on subsidiary dividends","excerpt":"insurance operations. Such dividends are subject to local insurance regulatory requirements, as discussed in “— Liquidity and Capital Sources and Uses — Dividends from Subsidiaries.”"},{"id":"e27","sourceId":"filing-2","location":"Investments — commercial and agricultural mortgage credit-quality distributions","excerpt":"The distribution of our commercial mortgage loan portfolios totaling $39.6 billion at amortized cost at June 30, 2026 by key credit quality indicators of LTV and DSCR was as follows: June 30, 2026 DSCR LTV > 1.2x 1.0-1.2x < 1.0x Total <65% 53.3 % 1.3 % 1.4 % 56.0 % 65% - 75% 12.7 % 1.6 % 1.3 % 15.6 % 76% - 80% 4.6 % 0.1 % 0.6 % 5.3 % >80% 13.8 % 4.9 % 4.4 % 23.1 % Total 84.4 % 7.9 % 7.7 % 100.0 % The distribution of our agricultural mortgage loan portfolios totaling $18.5 billion at amortized cost at June 30, 2026 by the key credit quality indicator of LTV was as follows: June 30, 2026 LTV Total <65% 92.0 % 65% - 75% 6.8 % 76% - 80% 0.2 % >80% 1.0 % Total 100.0 % 132 Table of Contents Mortgage Loan ACL."},{"id":"e28","sourceId":"filing-2","location":"Related Party Transactions — Chariot Re receivables and funds withheld liabilities","excerpt":"The Company has entered into reinsurance agreements with Chariot Re, a subsidiary of Chariot, and recorded premiums, reinsurance and other receivables of $10.9 billion and $9.8 billion and a funds withheld liability of $11.1 billion and $10.5 billion within other liabilities at June 30, 2026 and December 31, 2025, respectively."},{"id":"e29","sourceId":"filing-1","location":"Risk Factors — continuing direct-insurer liability after reinsurance","excerpt":"We remain liable and may incur costs as the direct insurer on all risks we reinsure as a result of a reinsurer’s insolvency, inability or unwillingness to make payments, or inability or unwillingness to maintain collateral, which could have a material adverse impact on our business, results of operations or financial condition."},{"id":"e30","sourceId":"filing-2","location":"Issuer Purchases — actual second-quarter 2026 share repurchases","excerpt":"or its affiliates during the quarter ended June 30, 2026 are set forth below: Period Total Number of Shares Purchased (1) Average Price Paid per Share Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs Maximum Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under the Plans or Programs (2) April 1 - April 30, 2026 2,610,199 $ 74.52 2,610,199 $ 1,122,489,017 May 1 - May 31, 2026 3,406,311 $ 81.03 3,406,311 $ 846,489,489 June 1 - June 30, 2026 2,652,706 $ 84.44 2,652,706 $ 622,489,077 Total 8,669,216 8,669,216 __________________ (1)During the periods presented, separate account index funds did not purchase any MetLife, Inc."},{"id":"e31","sourceId":"filing-1","location":"Equity Compensation Plan Information — outstanding awards and available issuance","excerpt":"321 Table of Contents The following table provides information regarding MetLife, Inc.’s equity compensation plans: Equity Compensation Plan Information at December 31, 2025: Number of Securities to be Issued upon Exercise of Outstanding Options, Warrants and Rights (1) Weighted-average Exercise Price of Outstanding Options, Warrants and Rights (2) Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in Column (a)) (3) Plan Category (a) (b) (c) Equity compensation plans approved by security holders 10,457,532 $ 56.85 21,489,793 Equity compensation plans not approved by security holders None — None Total 10,457,532 $ 56.85 21,489,793 ______________ (1) Column (a) reflects the following items outstanding at December 31, 2025: Stock Options (i) 2,682,613 Restricted Stock Units (ii) 2,142,966 Performance Shares (assuming future payout at maximum performance factor) (ii) 4,737,559 Deferred Shares (iii) 894,394 Shares that will or may be issued 10,457,532 ______________ (i) Stock Options granted under the MetLife, Inc."},{"id":"e32","sourceId":"filing-2","location":"Stock-Based Compensation — actual settlement of 2023 performance awards","excerpt":"Performance Shares and Performance Units granted in 2023 were among the outstanding awards on the expiration date of the 2015 Stock Plan, which were settled in the first quarter of 2026."},{"id":"e33","sourceId":"filing-2","location":"Stock-Based Compensation — realized three-year performance factor","excerpt":"The performance factor for the January 1, 2023 – December 31, 2025 performance period was 57.50%, which was determined within a possible range from 0% to 175%."},{"id":"e34","sourceId":"filing-3","location":"Executive Compensation — variable pay, share ownership guidelines and multiyear vesting","excerpt":"Key Features of MetLife’s Executive Compensation Program MetLife’s compensation program has multiple features that promote the Company’s success, including: •paying for performance: the vast majority of compensation is variable without guarantee, and dependent on achieving business and TSR results; •aligning executives’ interests with those of shareholders: the vast majority of executive incentive compensation is share-based, and employees at the Senior Vice-President level and above are expected to meet share ownership guidelines; •encouraging long-term decision making: the ultimate value of Performance Shares is determined by the Company’s performance over three years, and Restricted Stock Units vest over three years; •rewarding achievement of the Company’s business goals: annual incentive awards are based on Company performance compared to its Business Plan; individual awards reflect individual contributions related to achieving annual goals; •avoiding incentives to take excessive risk: the Company does not make formulaic individual awards, uses Adjusted Earnings (which excludes net investment gains and losses, net derivative gains and losses, and market risk benefit remeasurement gains and losses) as a key performance indicator, avoids incentives to take excessive risks in the Company’s investment portfolio, and uses multi-year performance to determine the payout of LTI."},{"id":"e35","sourceId":"filing-3","location":"Executive Compensation — reinsurance-related charge excluded from annual incentive earnings","excerpt":"Management excluded a charge of $31 million, net of income tax, related to the forgone earnings impacts of these transactions from the 2025 AVIP Adjusted Earnings."},{"id":"e36","sourceId":"filing-3","location":"Executive Compensation — Mexico tax charges excluded from annual incentive earnings","excerpt":"Management excluded these charges from the 2025 AVIP Adjusted Earnings as this resolution and related change in tax law was not known at the time the 2025 Business Plan was approved."},{"id":"e37","sourceId":"filing-3","location":"Corporate Governance — independent principal standing committees","excerpt":"Each of the Principal Standing Committees is composed entirely of Independent Directors and chaired by an Independent"},{"id":"e38","sourceId":"filing-3","location":"Corporate Governance — audit committee oversight of auditor independence and performance","excerpt":"The Audit Committee evaluates the independent auditor’s qualifications, performance, and independence, reviews and evaluates the lead partner on the independent auditor’s engagement, and presents its conclusions to the Board."},{"id":"e39","sourceId":"filing-2","location":"Risk disclosures — policyholder trust voting influence","excerpt":"separation risks; (37) MetLife, Inc.’s Board of Directors influence over the outcome of stockholder votes through the voting provisions of the MetLife Policyholder Trust; and (38) legal- and corporate governance-related effects on business combinations."},{"id":"e40","sourceId":"filing-1","location":"Investments — realized real estate and joint venture income","excerpt":"Real estate investments, by income type, as well as income earned, were as follows at and for the periods indicated: December 31, Years Ended December 31, 2025 2024 2025 2024 2023 Income Type Carrying Value Income (In millions) Wholly-owned real estate: Leased real estate $ 4,174 $ 4,283 $ 358 $ 341 $ 366 Other real estate 710 650 364 291 297 REJV 8,556 8,409 125 (192) (225) Total real estate and REJV $ 13,440 $ 13,342 $ 847 $ 440 $ 438 Depreciation expense on real estate investments was $117 million, $124 million and $112 million for the years ended December 31, 2025, 2024 and 2023, respectively."},{"id":"e41","sourceId":"filing-2","location":"Related Party Transactions — unfunded Chariot capital commitments","excerpt":"The Company had unfunded contingent capital commitments to Chariot of $67 million and $94 million at June 30, 2026 and December 31, 2025, respectively."},{"id":"e42","sourceId":"filing-3","location":"Executive performance — completed PineBridge acquisition","excerpt":"PineBridge Investments acquisition, including implementing new governance structures."},{"id":"e43","sourceId":"filing-1","location":"Cover page — common shares outstanding at February 12, 2026","excerpt":"At February 12, 2026, 652,053,867 shares of the registrant’s common stock were outstanding."},{"id":"e44","sourceId":"filing-3","location":"Executive performance — issuer-reported process improvement benefits","excerpt":"•Exceeded financial benefit targets by reengineering end-to-end processes using composite AI solutions across call centers, claims, and policy administration."}],"changes":["Retain the previous uncertain verdict: current franchise strengths still lack demonstrated durable competitive superiority.","Add bounded contractual persistence from nonsurrenderable payout annuities and reported Latin America persistency; neither establishes company-wide switching costs.","Recognize disclosed group-policy repricing flexibility alongside guarantees and regulatory constraints; realized premium pricing remains unestablished.","Add actual compensation settlements, governance disclosures and insurance-specific financial assessments. The supplied proxy identifies named business and/or investor peers, although segment-level competitive comparisons remain absent."],"limitations":["All evidence comes from issuer filings. Reported results and contractual terms support numerical assessments, while brand, strategy and efficiency assertions receive less weight.","Competitor names come from a proxy peer group covering competition for business and/or investors. The passages do not establish each named company's overlap in individual products or relative costs, retention and pricing.","No realized insurance rate changes, rate-versus-volume decomposition, company-wide renewal rates or comparative underwriting economics are supplied.","Certain payout annuities prohibit surrender, but their economic materiality and incremental returns are not disclosed. Reported persistency is regional and unquantified.","The combined RBC measure covers specified principal U.S. subsidiaries, excludes American Life and uses company action level RBC. It does not establish group-wide or foreign solvency, and its disclosed lower bounds do not establish exact year-over-year ratio changes.","Comprehensive reserve development, reinsurance collateral sufficiency, credit losses, liquidity stress coverage and asset/liability duration matching are absent.","Compensation design and actual performance settlements are disclosed, but individual executive ownership balances and compliance with ownership guidelines are not supplied.","Financial grades use filings dated February 19, April 29, May 7 and August 6, 2026, all within 550 days of October 18, 2026. Dates retain their supplied filed classification; older filings do not establish current sufficiency."],"qualityAssessments":[{"category":"moat","checks":[{"criterion":"structural_advantage","grade":null,"rationale":"Funding access, service benchmarks and selected surrender restrictions establish franchise strengths, but their competitive economic advantage is unresolved.","evidenceIds":["e1","e2","e9","e6"]},{"criterion":"durability","grade":null,"rationale":"Contractual persistence is bounded to selected products; sustained superior returns attributable to a defensible mechanism are not established.","evidenceIds":["e8","e9","e19"]},{"criterion":"customer_dependency","grade":null,"rationale":"Nonsurrenderable annuities and reported regional persistency provide partial evidence, but cannot establish company-wide customer dependency.","evidenceIds":["e9","e18"]},{"criterion":"erosion_resilience","grade":null,"rationale":"Operating growth coexists with disclosed competitive disadvantages. The passages do not establish resilience of a specific moat, and technology risks are prospective.","evidenceIds":["e18","e6","e7"]}]},{"category":"pricing_power","checks":[{"criterion":"realized_pricing","grade":null,"rationale":"Revenue growth and competitor pricing disclosures do not isolate MetLife's realized insurance prices. Repricing flexibility establishes ability, not exercised pricing outcomes.","evidenceIds":["e18","e6","e12"]},{"criterion":"retention","grade":2,"rationale":"Reported solid Latin America persistency and nonsurrenderable payout contracts support repeat demand and contractual persistence. Evidence is regional or product-specific, without a company-wide retention rate; growth is an indirect additional indicator.","evidenceIds":["e18","e9","e2"]},{"criterion":"margin_resilience","grade":2,"rationale":"Renewal adjustments and hedging mitigate interest-rate pressure, but guarantees constrain retained asset accounts and disability reserves. First-half earnings improved, without isolating pricing's contribution. Scenario disclosures are not treated as proof of current realized compression.","evidenceIds":["e12","e13","e14","e15","e16","e20","e21"]},{"criterion":"contractual_freedom","grade":2,"rationale":"Renewable group life and disability policies permit adjustments, while guarantees constrain other obligations and regulatory processes can limit timely repricing. Freedom varies materially by product.","evidenceIds":["e10","e12","e14","e16","e17"]}]},{"category":"strong_management","checks":[{"criterion":"capital_discipline","grade":2,"rationale":"Actual repurchases, positive earnings and disclosed capital support active capital management. Lower 2025 GAAP returns, reduced holding-company liquidity and incomplete acquisition-return evidence make discipline mixed rather than exceptional.","evidenceIds":["e19","e21","e24","e25","e30","e42"]},{"criterion":"incentive_alignment","grade":2,"rationale":"Multiyear share-based incentives were implemented, and settled awards used a 57.50% performance factor within a 0–175% range. Discretionary exclusions from annual incentive earnings weaken a purely mechanical link to shareholder outcomes; actual executive ownership is missing.","evidenceIds":["e32","e33","e34","e35","e36"]},{"criterion":"execution","grade":2,"rationale":"Reported growth, service benchmarks, completed acquisition activity and improved first-half 2026 earnings support execution. This partly indirect operating assessment is tempered by lower 2025 GAAP earnings and ROE; claimed process benefits lack quantified verification.","evidenceIds":["e18","e2","e19","e20","e21","e42","e44"]},{"criterion":"governance","grade":2,"rationale":"Independent principal committees and auditor oversight are concrete governance arrangements. Policyholder trust voting influence and compensation adjustments qualify their strength; no realized governance failure is inferred from the risk disclosure.","evidenceIds":["e37","e38","e39","e35","e36"]}]}],"financialAssessments":[{"category":"financial_strength","checks":[{"criterion":"capital_adequacy","grade":3,"rationale":"At year-end 2025, the internally defined ratio exceeded 350%, using aggregate total adjusted capital divided by aggregate company action level RBC, including SCL effects, for specified principal U.S. insurance subsidiaries excluding American Life. This demonstrates substantial capital in that scope, not consolidated or foreign solvency; no denominator conversion or exact headroom is inferred.","evidenceIds":["e22","e23","e24"]},{"criterion":"liquidity_funding","grade":2,"rationale":"Holding-company liquid assets were $3.4 billion at June 2026 versus $3.6 billion at year-end 2025, with reported ratings-supported wholesale access. Regulatory restrictions on subsidiary dividends and missing stressed cash requirements prevent a stronger sufficiency conclusion.","evidenceIds":["e25","e1","e26"]},{"criterion":"asset_liability_risk","grade":2,"rationale":"Mortgage collateral and debt-service distributions provide tangible investment-risk evidence, including 7.7% of commercial mortgages with DSCR below 1.0x. Guarantees, substantial reinsurance receivables and retained direct-insurer liability create offsetting exposures. Hedging is disclosed, but comprehensive matching and recoverability evidence is missing.","evidenceIds":["e27","e28","e29","e13","e14","e15"]},{"criterion":"earnings_resilience","grade":2,"rationale":"Common-shareholder GAAP income declined from $4.226 billion in 2024 to $3.173 billion in 2025, then increased from $1.577 billion to $1.845 billion in the first half of 2026. Continued profitability is demonstrated, alongside investment and derivative losses and meaningful annual variability.","evidenceIds":["e19","e20","e21"]}]},{"category":"capital_allocation","checks":[{"criterion":"capital_efficiency","grade":2,"rationale":"Reported return on MetLife common stockholder equity was 12.9% in 2025 versus 16.9% in 2024. These GAAP common-equity returns support productive but variable capital use; they are not returns on regulatory or economic capital and do not establish a competitive moat.","evidenceIds":["e19"]},{"criterion":"distributions_and_buffers","grade":2,"rationale":"MetLife actually repurchased 8,669,216 shares in the second quarter of 2026 while remaining profitable, with disclosed U.S. insurance capital and holding-company liquidity. Falling liquid assets and incomplete total distribution and statutory remittance coverage prevent a strong judgment about sustainable payout capacity.","evidenceIds":["e30","e21","e24","e25","e26"]},{"criterion":"dilution_and_cost","grade":2,"rationale":"Actual buybacks offset potential issuance, while 10,457,532 shares were issuable under outstanding equity awards at year-end 2025 and performance awards were subsequently settled. A current share count and financing expense are disclosed, but compensation expense, a complete net-share bridge and financing terms are missing.","evidenceIds":["e30","e31","e32","e43","e20"]},{"criterion":"investment_discipline","grade":2,"rationale":"Real estate and joint venture income improved to $847 million in 2025 from $440 million in 2024, although joint ventures had losses in earlier comparison years. Mortgage risk distributions and Chariot commitments permit a mixed assessment of investment exposure. PineBridge completion and revenue contribution do not establish acquisition returns; reinsurance recoverability remains unresolved.","evidenceIds":["e40","e27","e41","e28","e29","e42","e18"]}]}],"qualityPolicy":"quality-scores-2","sourcePolicy":"issuer-evidence-4","financialAssessmentPolicy":"financial-industry-1","financialSector":"insurance","basisHash":"eb618fba6ddc567d69c973781798f48a6d98ecb028de264d85b77bca2814023d","updatedAt":"2026-10-18T13:26:11.959Z","sources":[{"id":"filing-1","url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921926000013/met-20251231.htm","publishedAt":"2026-02-19","sha256":"37a42832ea4d5c485a05bc905f43cd5efbb40682bc77900ca5c3e22c68e166a0","dateKind":"filed"},{"id":"filing-2","url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921926000050/met-20260630.htm","publishedAt":"2026-08-06","sha256":"ff54ed367cd39ed358a3ec3ed271fc05bfc5afa31e9656a1471307429a4771a6","dateKind":"filed"},{"id":"filing-3","url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921926000026/met-20260429.htm","publishedAt":"2026-04-29","sha256":"28b175f133d328405d3e73ca181234012422a9414acb7b29cae1aad75f6694a0","dateKind":"filed"},{"id":"filing-4","url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921925000044/met-20241231.htm","publishedAt":"2025-02-21","sha256":"c0596355409b4a2021b935f2ee80e1585ee0b6e6617bd9627605948f140b82a3","dateKind":"filed"},{"id":"filing-5","url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921924000035/met-20231231.htm","publishedAt":"2024-02-16","sha256":"ea0fc401802cd527c382b6021d854a4b4791ce6877511ec589c8c6a47dc43578","dateKind":"filed"},{"id":"filing-6","url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921926000035/met-20260331.htm","publishedAt":"2026-05-07","sha256":"b511fefa0099c4b7722b4d00f3449182116e9d7fc0e4e780454d102e664f64b3","dateKind":"filed"}],"model":"gpt-6.1-sol","providerId":"codex:d1b2d9ba0147a9789670fc106ff17eebf8a70137d4bcfa3997eef70e69d59694","usage":{"input_tokens":93771,"cached_input_tokens":21120,"cache_write_input_tokens":0,"output_tokens":5439,"reasoning_output_tokens":170},"basisSupplement":{"previousHash":"0f651a1e05973f7d1028fb4f089330d7e24f7600ef8a36a9943e738a2ac56364","checkedAt":"2026-10-18T16:49:32.080Z","rule":"dated historical and missing inputs only; accepted observations and research date retained"}},"signals":[{"period":"2021","end":"2021-12-31","values":{"gross_margin":null,"operating_margin":null,"roic":null,"fcf_margin":null,"sbc_revenue":null},"issues":{"pfcf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","pfcf_growth":"Two complete TTM FCF bases and their diluted share counts are required for year-over-year growth.","fcf_yield":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","ev_sales":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","ev_ebitda":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","capex":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","fcf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","sbc":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","software_capex":"Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.","sbc_fcf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","sbc_ocf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","gross_margin":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","operating_margin":"Operating income is unavailable in the extracted statements for this period.","ebitda_margin":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","fcf_margin":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","capex_intensity":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","sbc_revenue":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","roic":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","roce":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","roiic":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","roic_wacc":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","net_debt_ebitda":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","debt_fcf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","interest_coverage":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","current_ratio":"The reported inputs required for this metric are unavailable in the extracted statements for this period."}},{"period":"2022","end":"2022-12-31","values":{"gross_margin":null,"operating_margin":283.3175355450237,"roic":null,"fcf_margin":null,"sbc_revenue":null},"issues":{"peg":"TTM earnings per diluted share growth is zero or negative; a growth-adjusted multiple requires positive growth.","pfcf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","pfcf_growth":"Two complete TTM FCF bases and their diluted share counts are required for year-over-year growth.","fcf_yield":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","ev_sales":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","ev_ebitda":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","capex":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","fcf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","sbc":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","software_capex":"Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.","sbc_fcf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","sbc_ocf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","gross_margin":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","ebitda_margin":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","fcf_margin":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","capex_intensity":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","sbc_revenue":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","roic":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","roce":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","roiic":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","roic_wacc":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","net_debt_ebitda":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","debt_fcf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","interest_coverage":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","current_ratio":"The reported inputs required for this metric are unavailable in the extracted statements for this period."}},{"period":"2023","end":"2023-12-31","values":{"gross_margin":null,"operating_margin":256.7519066846119,"roic":null,"fcf_margin":null,"sbc_revenue":null},"issues":{"peg":"TTM earnings per diluted share growth is zero or negative; a growth-adjusted multiple requires positive growth.","pfcf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","pfcf_growth":"Two complete TTM FCF bases and their diluted share counts are required for year-over-year growth.","fcf_yield":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","ev_sales":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","ev_ebitda":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","capex":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","fcf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","sbc":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","software_capex":"Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.","sbc_fcf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","sbc_ocf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","gross_margin":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","ebitda_margin":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","fcf_margin":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","capex_intensity":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","sbc_revenue":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","roic":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","roce":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","roiic":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","roic_wacc":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","net_debt_ebitda":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","debt_fcf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","interest_coverage":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","current_ratio":"The reported inputs required for this metric are unavailable in the extracted statements for this period."}},{"period":"2024","end":"2024-12-31","values":{"gross_margin":null,"operating_margin":267.08240534521155,"roic":null,"fcf_margin":null,"sbc_revenue":null},"issues":{"pfcf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","pfcf_growth":"Two complete TTM FCF bases and their diluted share counts are required for year-over-year growth.","fcf_yield":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","ev_sales":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","ev_ebitda":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","capex":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","fcf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","sbc":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","software_capex":"Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.","sbc_fcf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","sbc_ocf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","gross_margin":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","ebitda_margin":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","fcf_margin":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","capex_intensity":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","sbc_revenue":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","roic":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","roce":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","roiic":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","roic_wacc":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","net_debt_ebitda":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","debt_fcf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","interest_coverage":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","current_ratio":"The reported inputs required for this metric are unavailable in the extracted statements for this period."}},{"period":"2025","end":"2025-12-31","values":{"gross_margin":null,"operating_margin":251.92939244663384,"roic":null,"fcf_margin":null,"sbc_revenue":null},"issues":{"peg":"TTM earnings per diluted share growth is zero or negative; a growth-adjusted multiple requires positive growth.","pfcf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","pfcf_growth":"Two complete TTM FCF bases and their diluted share counts are required for year-over-year growth.","fcf_yield":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","ev_sales":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","ev_ebitda":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","capex":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","fcf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","sbc":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","software_capex":"Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.","sbc_fcf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","sbc_ocf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","gross_margin":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","ebitda_margin":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","fcf_margin":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","capex_intensity":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","sbc_revenue":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","roic":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","roce":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","roiic":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","roic_wacc":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","net_debt_ebitda":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","debt_fcf":"The reported inputs required for this metric are unavailable in the extracted statements for this period.","interest_coverage":"Not applicable to banks and insurers: these ratios use an industrial-company capital model.","current_ratio":"The reported inputs required for this metric are unavailable in the extracted statements for this period."}}],"sources":[{"id":"filing-1","url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921926000013/met-20251231.htm","publishedAt":"2026-02-19","sha256":"37a42832ea4d5c485a05bc905f43cd5efbb40682bc77900ca5c3e22c68e166a0","dateKind":"filed"},{"id":"filing-2","url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921926000050/met-20260630.htm","publishedAt":"2026-08-06","sha256":"ff54ed367cd39ed358a3ec3ed271fc05bfc5afa31e9656a1471307429a4771a6","dateKind":"filed"},{"id":"filing-3","url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921926000026/met-20260429.htm","publishedAt":"2026-04-29","sha256":"28b175f133d328405d3e73ca181234012422a9414acb7b29cae1aad75f6694a0","dateKind":"filed"},{"id":"filing-4","url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921925000044/met-20241231.htm","publishedAt":"2025-02-21","sha256":"c0596355409b4a2021b935f2ee80e1585ee0b6e6617bd9627605948f140b82a3","dateKind":"filed"},{"id":"filing-5","url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921924000035/met-20231231.htm","publishedAt":"2024-02-16","sha256":"ea0fc401802cd527c382b6021d854a4b4791ce6877511ec589c8c6a47dc43578","dateKind":"filed"},{"id":"filing-6","url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921926000035/met-20260331.htm","publishedAt":"2026-05-07","sha256":"b511fefa0099c4b7722b4d00f3449182116e9d7fc0e4e780454d102e664f64b3","dateKind":"filed"}],"history":[{"version":4,"updatedAt":"2026-10-18T16:49:32.080Z","verdict":"uncertain","value":null},{"version":3,"updatedAt":"2026-10-18T16:35:43.872Z","verdict":"uncertain","value":null},{"version":2,"updatedAt":"2026-10-18T02:27:49.793Z","verdict":"uncertain","value":null},{"version":1,"updatedAt":"2026-10-18T02:18:02.026Z","verdict":null,"value":null}],"hasRequested":false,"requestStatus":"completed","researchIssue":null,"archivedMoat":null,"scope":"supported_catalog"}